The metabolic changes that occur in a cancer cell have been studied for a few decades, but our appreciation of the complexity and importance of those changes is now being realized. The metabolic switch from oxidative phosphorylation to aerobic glycolysis provides intermediates for cell growth and division and is regulated by both oncogenes and tumor suppressor genes. The p53 tumor suppressor gene has long been shown to play key roles in responding to DNA damage, hypoxia, and oncogenic activation. However, now p53 has added the ability to mediate metabolic changes in cells through the regulation of energy metabolism and oxidative stress to its repertoire of activities. It is therefore the focus of this review to discuss the metabolic pathways regulated by p53 and their cooperation in controlling cancer cell metabolism.
Warburg O.On respiratory impairment in cancer cells.Science. 1956;124 (3215): 269-70
2.
Yeung SJ,Pan J,Lee MH.Roles of p53, MYC and HIF-1 in regulating glycolysis: the seventh hallmark of cancer.Cell Mol Life Sci. 2008;65 (24): 3981-99
3.
Vousden KH,Ryan KM.p53 and metabolism.Nat Rev Cancer. 2009;9 (10): 691-700
4.
Pfeiffer T,Schuster S,Bonhoeffer S.Cooperation and competition in the evolution of ATP-producing pathways.Science. 2001;292 (5516): 504-7
5.
Christofk HR,Vander Heiden MG,Harris MH, et al.The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.Nature. 2008;452 (7184): 230-3
6.
Bensaad K,Vousden KH.p53: new roles in metabolism.Trends Cell Biol. 2007;17 (6): 286-91
Bensaad K,Tsuruta A,Selak MA, et al.TIGAR, a p53-inducible regulator of glycolysis and apoptosis.Cell. 2006;126 (1): 107-20
9.
Chipuk JE,Bouchier-Hayes L,Kuwana T,Newmeyer DD,Green DR.PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.Science. 2005;309 (5741): 1732-5
10.
Hu W,Zhang C,Wu R,Sun Y,Levine A,Feng Z.Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.Proc Natl Acad Sci U S A. 2010;107 (16): 7455-60
11.
Ide T,Brown-Endres L,Chu K, et al.GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress.Mol Cell. 2009;36 (3): 379-92
12.
Kondoh H,Lleonart ME,Gil J, et al.Glycolytic enzymes can modulate cellular life span.Cancer Res. 2005;65 (1): 177-85
Mihara M,Erster S,Zaika A, et al.p53 has a direct apoptogenic role at the mitochondria.Mol Cell. 2003;11 (3): 577-90
15.
Suzuki S,Tanaka T,Poyurovsky MV, et al.Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.Proc Natl Acad Sci U S A. 2010;107 (16): 7461-6
16.
Zhao Y,Coloff JL,Ferguson EC,Jacobs SR,Cui K,Rathmell JC.Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation.J Biol Chem. 2008;283 (52): 36344-53
17.
Ma W,Sung HJ,Park JY,Matoba S,Hwang PM.A pivotal role for p53: balancing aerobic respiration and glycolysis.J Bioenerg Biomembr. 2007;39 (3): 243-6
18.
Mathupala SP,Heese C,Pedersen PL.Glucose catabolism in cancer cells: the type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53.J Biol Chem. 1997;272 (36): 22776-80
19.
Shakya A,Cooksey R,Cox JE,Wang V,McClain DA,Tantin D.Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.Nat Cell Biol. 2009;11 (3): 320-7
20.
Zheng L,Roeder RG,Luo Y.S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component.Cell. 2003;114 (2): 255-66
21.
Coloff JL,Mason EF,Altman BJ, et al.AKT requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.J Biol Chem. 2011;286 (7): 5921-33
22.
Medes G,Thomas A,Weinhouse S.Metabolism of neoplastic tissue: IV. A study of lipid synthesis in neoplastic tissue slices in vitro.Cancer Res. 1953;13 (1): 27-9
23.
Fritz V,Fajas L.Metabolism and proliferation share common regulatory pathways in cancer cells.Oncogene. 2010;29 (31): 4369-77
24.
Ide T,Chu K,Aaronson SA,Lee SW.GAMT joins the p53 network: branching into metabolism.Cell Cycle. 2010;9 (9): 1706-10
D’Erchia AM,Tullo A,Lefkimmiatis K,Saccone C,Sbisa E.The fatty acid synthase gene is a conserved p53 family target from worm to human.Cell Cycle. 2006;5 (7): 750-8
27.
Buzzai M,Jones RG,Amaravadi RK, et al.Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.Cancer Res. 2007;67 (14): 6745-52
Carling D,Zammit VA,Hardie DG.A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis.FEBS Lett. 1987;223 (2): 217-22
30.
Jones RG,Thompson CB.Tumor suppressors and cell metabolism: a recipe for cancer growth.Genes Dev. 2009;23 (5): 537-48
31.
DeBerardinis RJ,Lum JJ,Hatzivassiliou G,Thompson CB.The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.Cell Metab. 2008;7 (1): 11-20
32.
Budanov AV,Karin M.p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.Cell. 2008;134 (3): 451-60
33.
Ellisen LW,Ramsayer KD,Johannessen CM, et al.REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.Mol Cell. 2002;10 (5): 995-1005
34.
Feng Z,Hu W,de Stanchina E, et al.The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.Cancer Res. 2007;67 (7): 3043-53
35.
Feng Z,Zhang H,Levine AJ,Jin S.The coordinate regulation of the p53 and mTOR pathways in cells.Proc Natl Acad Sci U S A. 2005;102 (23): 8204-9
36.
Stambolic V,MacPherson D,Sas D, et al.Regulation of PTEN transcription by p53.Mol Cell. 2001;8 (2): 317-25
37.
Brugarolas J,Lei K,Hurley RL, et al.Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.Genes Dev. 2004;18 (23): 2893-904
38.
Feng Z,Levine AJ.The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.Trends Cell Biol. 2010;20 (7): 427-34
39.
Reuter S,Gupta SC,Chaturvedi MM,Aggarwal BB.Oxidative stress, inflammation, and cancer: how are they linked?.Free Radic Biol Med. 2010;49 (11): 1603-16
40.
Budanov AV,Sablina AA,Feinstein E,Koonin EV,Chumakov PM.Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD.Science. 2004;304 (5670): 596-600
41.
Cano CE,Gommeaux J,Pietri S, et al.Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.Cancer Res. 2009;69 (1): 219-26
42.
Tan M,Li S,Swaroop M,Guan K,Oberley LW,Sun Y.Transcriptional activation of the human glutathione peroxidase promoter by p53.J Biol Chem. 1999;274 (17): 12061-6
43.
Yoon KA,Nakamura Y,Arakawa H.Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.J Hum Genet. 2004;49 (3): 134-40
44.
Chen W,Sun Z,Wang XJ, et al.Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response.Mol Cell. 2009;34 (6): 663-73
45.
Drane P,Bravard A,Bouvard V,May E.Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis.Oncogene. 2001;20 (4): 430-9
46.
Faraonio R,Vergara P,Di Marzo D, et al.p53 suppresses the Nrf2-dependent transcription of antioxidant response genes.J Biol Chem. 2006;281 (52): 39776-84
47.
Hussain SP,Amstad P,He P, et al.p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis.Cancer Res. 2004;64 (7): 2350-6
48.
Liu Z,Lu H,Shi H, et al.PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.Cancer Res. 2005;65 (5): 1647-54
49.
Polyak K,Xia Y,Zweier JL,Kinzler KW,Vogelstein B.A model for p53-induced apoptosis.Nature. 1997;389 (6648): 300-5
50.
Rivera A,Maxwell SA.The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway.J Biol Chem. 2005;280 (32): 29346-54
51.
Trinei M,Giorgio M,Cicalese A, et al.A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress–induced apoptosis.Oncogene. 2002;21 (24): 3872-8
52.
Liu B,Chen Y,St Clair DK.ROS and p53: a versatile partnership.Free Radic Biol Med. 2008;44 (8): 1529-35
53.
Ak P,Levine AJ.p53 and NF-kappaB: different strategies for responding to stress lead to a functional antagonism.FASEB J. 2010;24 (10): 3643-52
54.
Kawauchi K,Araki K,Tobiume K,Tanaka N.p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation.Nat Cell Biol. 2008;10 (5): 611-8
55.
Wells L,Kreppel LK,Comer FI,Wadzinski BE,Hart GW.O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits.J Biol Chem. 2004;279 (37): 38466-70
56.
Haltiwanger RS,Holt GD,Hart GW.Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins: identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.J Biol Chem. 1990;265 (5): 2563-8
57.
Kornfeld S,Kornfeld R,Neufeld EF,O’Brien PJ.The feedback control of sugar nucleotide biosynthesis in liver.Proc Natl Acad Sci U S A. 1964;52:371-9
58.
Yang WH,Kim JE,Nam HW, et al.Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.Nat Cell Biol. 2006;8 (10): 1074-83
59.
Kawauchi K,Araki K,Tobiume K,Tanaka N.Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification.Proc Natl Acad Sci U S A. 2009;106 (9): 3431-6
